Atrovent Hfa en es it fr

Atrovent Hfa Brand names, Atrovent Hfa Analogs

Atrovent Hfa Brand Names Mixture

  • Combivent Inhalation Aerosol (Ipratropium Bromide + Salbutamol Sulfate)
  • Combivent Inhalation Solution (Ipratropium Bromide + Salbutamol Sulfate)
  • Duovent Udv (Fenoterol Hydrobromide + Ipratropium Bromide)
  • Ratio-Ipra Sal Udv (Ipratropium Bromide + Salbutamol Sulfate)

Atrovent Hfa Chemical_Formula


Atrovent Hfa RX_link

Atrovent Hfa fda sheet

Atrovent_Hfa FDA

Atrovent Hfa msds (material safety sheet)

Atrovent Hfa Synthesis Reference

K. Zeile et al.,U.S. Pat. 3,505,337 (1970)

Atrovent Hfa Molecular Weight

332.457 g/mol

Atrovent Hfa Melting Point


Atrovent Hfa H2O Solubility

Freely soluble

Atrovent Hfa State


Atrovent Hfa LogP

No information avaliable

Atrovent Hfa Dosage Forms

Aerosol (with propellants); Liquid; Metered-dose (aerosol); Metered-dose (pump); Solution

Atrovent Hfa Indication

For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Atrovent Hfa Pharmacology

Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the management of cholinergic-mediated bronchospasm associated with chronic obstructive pulmonary disease and in the treatment of rhinorrhea associated with the common cold or with allergic or nonallergic seasonal rhinitis.

Atrovent Hfa Absorption

Inhalation (local)-minimal; Nasal-rapid and minimal

Atrovent Hfa side effects and Toxicity

LD50=1001mg/kg (orally in mice)

Atrovent Hfa Patient Information

Atrovent Hfa Organisms Affected

Humans and other mammals